Nov. 17, 2023: Advocacy Update spotlight on the 2023 AMA Interim Meeting
Highlights from the 2023 AMA Interim Meeting and more in the latest Advocacy Update spotlight.
Council on Science & Public Health reports
Download PDFs of CSAPH reports presented at the AMA House of Delegates Interim and Annual Meetings.
AMA strengthens policy to address growing national drug shortages
New policy aimed at diversifying drug manufacturing, supply chains and stabilizing generic drug market to combat drug supply shortages.
Top news stories from AMA Morning Rounds®: Week of Nov. 6, 2023
In the news: FDA handling of drug shortage under investigation, congenital syphilis on the rise, childhood vaccine exemptions hit record high and more.
Reforms needed to alleviate persistent drug shortages
Federal regulators and Congress need to act now to eliminate persistent drug shortages that threaten patient health and well-being.
Top news stories from AMA Morning Rounds®: Week of March 20, 2023
In the news: Alarming spread of deadly and drug-resistant Candida auris fungus, growing drug shortages, autism spectrum disorder on the rise and more.
Prescription drugs: CSAPH reports
Download PDFs of reports on this topic for the Council on Science and Public Health (CSAPH) presented during the AMA Interim and Annual Meetings.
COVID-19 policy recommendations for OUD, pain, harm reduction
Download guidance and issue brief PDFs—the AMA provides policy recommendations to help guide policymakers to reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.